May 19, 2021 -- The National Institute of Bioprocessing Research and Training (NIBRT) in Ireland and Univercells Technologies are collaborating to address the need for training in cell and gene therapies (CGT) with installation of new equipment at NIBRT's Dublin facility.
Univercells' intermediate-capacity scale-X carbo system, featuring a fixed-bed bioreactor and in-line concentration, will be installed to provide hands-on demonstration and training to support continued education and workforce sustainability. The bioreactor will help train up workers from basic to expert-level biopharmaceutical professionals, according to the firms.
This effort is in response to the rapid growth of cell and gene therapy, which requires complex manufacturing processes that has created a shortage of highly skilled CGT manufacturing staff.
NIBRT will employ the fully operational scale-X carbo bioreactor for dedicated cell culture and viral manufacturing training courses for academia and industry experts beginning in the third quarter of 2021.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
